Anxiety, Alzheimer's Tx Flops; Suicidal Ideation in Kids, Too

<![CDATA[]]>(MedPage Today) — Biohaven’s investigational anxiety treatment troriluzole failed in an 8-week phase III trial.
Two investigational Alzheimer’s disease treatments — Eli Lilly’s solanezumab and Roche’s gantenerumab — both flopped in trials…

Source link

Related posts

Morning Break: Kratom to Schedule I; Placebos Reconsidered; Oh, This Is Definitely Our Lane


Better seizure control with ketogenic diet in infants with genetic epilepsy


What Happens to the Children When Parents Fight?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World